Dure geneesmiddelen * (extramuraal), de vergoeding in 2018

  • Raming voor de totale Zvw-populatie
  2014 2015 2016 2017 2018
Rang
2018
ATC-code  
1 R07AX30 Ivacaftor met lumacaftor (Orkambi ®)       5.765.200 89.532.400
2 N04BA02 Levodopa met decarboxylaseremmer (Madopar ®) 25.144.300 28.568.100 31.932.200 35.995.500 38.288.800
3 J05AR13 Lamivudine met abacavir en dolutegravir (Triumeq ®) 497.440 16.215.800 28.113.000 32.077.600 35.035.100
4 J05AR18 Emtricitabine tenofovir alafenamide elvitegravir cobicista (Genvoya ®)     8.899.200 26.089.100 33.297.700
5 C10AX13 Evolocumab (Repatha ®)     5.749.500 20.209.900 33.009.600
6 N07XX09 Dimethylfumaraat (Tecfidera ®) 2.470.700 16.075.200 20.508.000 23.228.100 32.174.400
7 L04AD02 Tacrolimus (Prograft ®) 24.963.500 26.778.400 28.406.600 29.575.200 31.476.200
8 L04AA27 Fingolimod (Gilenya ®) 18.239.400 21.522.300 22.922.700 24.383.400 27.108.300
9 B03XA02 Darbepoetine alfa (Aranesp ®) 25.997.300 24.510.900 24.142.800 24.134.500 26.269.200
10 H01CB02 Octreotide (Sandostatine ®) 23.178.700 24.552.000 24.447.000 23.381.300 23.438.000
11 H01CB03 Lanreotide (Somatuline ®) 12.440.200 15.102.000 16.761.300 18.777.100 20.785.200
12 C10AX14 Alirocumab (Praluent ®)     1.933.100 9.789.700 20.028.800
13 C02KX04 Macitentan (Opsumit ®) 2.475.300 7.469.900 12.530.200 15.309.000 18.946.000
14 A09AA02 Multi-enzymen (lipase protease enz) (Creon ®) 14.932.800 15.975.500 16.827.800 17.931.600 18.885.500
15 L03AB07 Interferon beta 1a (Avonex ®) 39.781.200 30.934.500 25.303.700 20.277.200 17.090.200
16 L03AX13 Glatirameer (Copaxone ®) 19.422.800 18.548.800 19.466.200 17.143.900 16.585.900
17 L03AA13 Pegfilgrastim (Neulasta ®) 29.500.500 23.793.500 17.682.400 14.646.000 16.180.400
18 L02AE02 Leuproreline (Lucrin pds ®) 14.339.600 14.299.900 14.602.400 15.245.300 15.815.600
  Totaal 253.383.740 284.346.800 320.228.100 373.959.600 513.947.300